These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4311212)

  • 41. Role of interferon in murine lactic dehydrogenase virus infection, in vivo and in vitro.
    Dubuy H; Baron S; Uhlendorf C; Johnson ML
    Infect Immun; 1973 Dec; 8(6):977-84. PubMed ID: 4361729
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Interferon as viral inhibitor induced by heterologous DNA.
    Holstein BA; Kohan SS; De la Peña NC; Teyssie AR; Lustig ES; Pirosky RR
    Acta Virol; 1971 Sep; 15(5):381-6. PubMed ID: 4399136
    [No Abstract]   [Full Text] [Related]  

  • 43. Antiviral and antimetabolic activities of neplanocins.
    De Clercq E
    Antimicrob Agents Chemother; 1985 Jul; 28(1):84-9. PubMed ID: 2994559
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Inducers of interferon and host resistance. VI. Antiviral efficacy of poly I:C in animal models.
    Nemes MM; Tytell AA; Lampson GP; Field AK; Hilleman MR
    Proc Soc Exp Biol Med; 1969 Nov; 132(2):776-83. PubMed ID: 5355140
    [No Abstract]   [Full Text] [Related]  

  • 45. Chronic viral neuropathies: models for study and food for thought.
    Koprowski H
    Int Arch Allergy Appl Immunol; 1969; 36():Suppl:158-81. PubMed ID: 4313663
    [No Abstract]   [Full Text] [Related]  

  • 46. Induction of the interferon mechanism by single-stranded RNA: potentiation by polybasic substances.
    Billiau A; Buckler CE; Dianzani F; Uhlendorf C; Baron S
    Proc Soc Exp Biol Med; 1969 Nov; 132(2):790-6. PubMed ID: 4311213
    [No Abstract]   [Full Text] [Related]  

  • 47. The role of interferon in the protective effect of a synthetic double-stranded polyribonucleotide against intranasal vesicular stomatitis virus challenge in mice.
    De Clercq E; Nuwer MR; Merigan TC
    J Clin Invest; 1970 Aug; 49(8):1565-77. PubMed ID: 4317283
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Enhancement of non-specific antiviral defence mechanisms in NMRI-mice by cell culture mediators.
    Reubel G; Büttner M; Mayr A
    Zentralbl Veterinarmed B; 1986 Oct; 33(8):557-67. PubMed ID: 2432743
    [No Abstract]   [Full Text] [Related]  

  • 49. Inducers of interferon and host resistance. II. Multistranded synthetic polynucleotide complexes.
    Field AK; Tytell AA; Lampson GP; Hilleman MR
    Proc Natl Acad Sci U S A; 1967 Sep; 58(3):1004-10. PubMed ID: 5233831
    [No Abstract]   [Full Text] [Related]  

  • 50. Viral infection and resistance in immunosuppressed host. II. Stimulatory effect and morphology following a single injection of an interferon inducer of the double-stranded RNA type.
    Mitrová E; Mayer V
    Acta Virol; 1973 Jan; 17(1):18-28. PubMed ID: 4405392
    [No Abstract]   [Full Text] [Related]  

  • 51. Response of Three Different Viruses to Interferon Priming and Dithiothreitol Treatment of Avian Cells.
    Lostalé-Seijo I; Martínez-Costas J; Benavente J
    J Virol; 2016 Sep; 90(18):8328-40. PubMed ID: 27440902
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Research on correlation between refractory state to the synthesis of interferon and state of antiviral resistance].
    Rousset S; Fournier F; Chany C
    C R Acad Hebd Seances Acad Sci D; 1970 Jul; 271(2):267-9. PubMed ID: 4317827
    [No Abstract]   [Full Text] [Related]  

  • 53. Inhibition of RNA and interferon synthesis in Krebs-2 cells infected with vesicular stomatitis virus.
    Wagner RR; Huang AS
    Virology; 1966 Jan; 28(1):1-10. PubMed ID: 4159265
    [No Abstract]   [Full Text] [Related]  

  • 54. Activation of TBK1 and IKKvarepsilon kinases by vesicular stomatitis virus infection and the role of viral ribonucleoprotein in the development of interferon antiviral immunity.
    tenOever BR; Sharma S; Zou W; Sun Q; Grandvaux N; Julkunen I; Hemmi H; Yamamoto M; Akira S; Yeh WC; Lin R; Hiscott J
    J Virol; 2004 Oct; 78(19):10636-49. PubMed ID: 15367631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Relationship of molecular size of rIn:rCn (poly I:C) to induction of interferon and host resistance.
    Lampson GP; Field AK; Tytell AA; Nemes MM; Hilleman MR
    Proc Soc Exp Biol Med; 1970 Dec; 135(3):911-6. PubMed ID: 4321038
    [No Abstract]   [Full Text] [Related]  

  • 56. Development of tissue viral resistance in chickens following administration of interferon inducers.
    Finkelstein MS
    J Immunol; 1972 Jun; 108(6):1506-16. PubMed ID: 4337965
    [No Abstract]   [Full Text] [Related]  

  • 57. Induction of interferon in L cells by defective-interfering (DI) particles of vesicular stomatitis virus: lack of correlation with content of [+/-] snapback RNA.
    Frey TK; Jones EV; Cardamone JJ; Youngner JS
    Virology; 1979 Nov; 99(1):95-102. PubMed ID: 227167
    [No Abstract]   [Full Text] [Related]  

  • 58. [In vitro synthesis of interferon in various simian tissues].
    Duc Goiran P; Chany C
    Ann Inst Pasteur (Paris); 1969 Nov; 117(5):724-38. PubMed ID: 4312559
    [No Abstract]   [Full Text] [Related]  

  • 59. Interferon production by mouse leukocytes in vitro and in vivo.
    GLASGOW LA; HABEL K
    J Exp Med; 1963 Jan; 117(1):149-60. PubMed ID: 13948365
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chemotherapy of human oncogenic viral infections: the possible role of interferon and reverse transcriptase inhibitors.
    Carter WA
    J Surg Oncol; 1973; 5(2):113-36. PubMed ID: 4122214
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.